The Low-T lawsuits were consolidated for the purpose of general pretrial discovery. Read more
Dr. Gerstman is an expert for the Plaintiffs’ Steering Committee (PSC). Read more
The Food and Drug Administration (FDA) is warning doctors against over-prescribing testosterone-boosting drugs for men, saying the popular treatments have not been established as safe or eff... Read more
Matt Teague, a lawyer in our Mass Tort section, was appointed by U.S. District Judge Matthew Kennelly to serve as a member of the Plaintiff’s Steering Committee (PSC) for MDL No. 2545, In re... Read more
We have again been asked to give an update on current activities in our firm’s Mass Torts Section. Lawyers in the Section have been very busy and are handling cases in several states in both... Read more
In a related matter, the U.S. Food and Drug Administration (FDA) is requiring manufacturers to include a general warning in the drug labeling of all approved testosterone products about the... Read more
On June 6, 2014, the United States Judicial Panel on Multidistrict Litigation (JPML) (the panel) established MDL No. 2545, In re: Testosterone Replacement Therapy Products Liability Litigati... Read more
On November 6, 2013, the Journal of the American Medical Association (JAMA) reported that “a recent randomized clinical trial of testosterone therapy in men with a high prevalence of cardiov... Read more
If you would like to subscribe to the Jere Beasley Report digital edition, simply visit our Subscriptions page and provide the necessary information or call us at 800-898-2034.
Attorney Advertising - Prior results do not guarantee a similar outcome.